Introduction: From Erectile Physiology to Urological Microcirculation Phosphodiesterase-5 (PDE-5) inhibitors were originally introduced into clinical practice as a revolutionary therapy for erectile dysfunction. Over time, however, their pharmacological relevance has extended far beyond the penile vasculature. Increasing evidence indicates that these agents—particularly sildenafil and tadalafil—exert important regulatory effects on vascular smooth muscle throughout the body. […]

Pulmonary arterial hypertension (PAH) remains one of the most challenging entities in cardiovascular and pulmonary medicine. It is rare, progressive, and, if left untreated, relentlessly fatal. Yet over the past three decades, the therapeutic landscape has transformed from therapeutic nihilism to structured, pathway-targeted, and increasingly aggressive pharmacotherapy. Contemporary registry data from Japan provide a particularly […]

Introduction: A Common Condition Hidden in Plain Sight Erectile dysfunction (ED) is not a rare or marginal condition. It is a highly prevalent, age-associated, vasculogenic and psychosocial disorder that affects quality of life as profoundly as many chronic systemic diseases. The definition is straightforward—persistent inability to achieve or maintain an erection sufficient for satisfactory sexual […]

Introduction Penile fibrosis represents one of the most complex and underappreciated pathophysiological processes contributing to erectile dysfunction (ED). It lies at the intersection of vascular compromise, smooth muscle apoptosis, hormonal deficiency, oxidative stress, and chronic inflammation. Unlike the transient hemodynamic changes that define common ED, penile fibrosis introduces a permanent structural component—a stiff, inelastic alteration […]

Introduction Radical prostatectomy remains a cornerstone in the management of localized prostate cancer. While surgical refinements and nerve-sparing approaches have significantly improved outcomes, erectile dysfunction (ED) continues to be one of the most prevalent and distressing sequelae. For many men, postoperative sexual dysfunction represents not just a physiological challenge but also an existential threat to […]

Introduction Cancer remains one of the greatest medical challenges of our era. While advances in genomics, immunotherapy, and targeted agents have transformed clinical outcomes in select cancers, metastasis and therapeutic resistance continue to drive mortality. The underlying biology of metastasis has been studied for decades, but the last two decades have crystallized one crucial concept: […]

Introduction The steady march of time leaves unmistakable footprints on the human body. While aging is a universal biological process, its consequences manifest with striking heterogeneity. Among the most insidious features of aging is the gradual rise in chronic low-grade inflammation, a phenomenon termed inflammaging. This persistent inflammatory state is now recognized as a central […]

Introduction Cancer remains one of the greatest medical challenges of our time, not only because of its uncontrolled cell proliferation but also due to its intricate relationship with chronic inflammation. Over the past two decades, research has revealed that inflammation is not a mere bystander but a driver of oncogenesis, tumor progression, metastasis, and therapy […]

Introduction Erectile dysfunction (ED) is often portrayed as an inevitable part of aging, a silent yet pervasive condition that robs men of confidence and intimacy. However, the story is far more complex. ED is not merely a urological inconvenience; it is a sentinel marker of vascular health, psychological well-being, and overall quality of life. In […]

Introduction Erectile dysfunction (ED) following prostate cancer treatment remains one of the most distressing complications for patients and their partners. For men undergoing definitive radiotherapy, whether external beam radiotherapy (EBRT) or brachytherapy, sexual function often deteriorates within months to years of treatment. Reported rates of moderate to severe ED range from 40% to 70% at […]